Importantly, we further predicted multiple candidate drugs with the potential to reverse the signature of gene expression changes in sepsis-induced ARDS, among which doxorubicin may contribute to reverse the expression mode in ARDS by targeting TOP2A. This evidence concerns the gene TOP2A and acute respiratory distress syndrome.